IN2012MN02924A - - Google Patents
Download PDFInfo
- Publication number
- IN2012MN02924A IN2012MN02924A IN2924MUN2012A IN2012MN02924A IN 2012MN02924 A IN2012MN02924 A IN 2012MN02924A IN 2924MUN2012 A IN2924MUN2012 A IN 2924MUN2012A IN 2012MN02924 A IN2012MN02924 A IN 2012MN02924A
- Authority
- IN
- India
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36933510P | 2010-07-30 | 2010-07-30 | |
| PCT/US2011/044926 WO2012015677A1 (en) | 2010-07-30 | 2011-07-22 | 6- (1-methyl-1h-pyrazol-4-yl)-3-(2-methyl-2h-indazol-5- |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2012MN02924A true IN2012MN02924A (en) | 2015-06-12 |
Family
ID=44513148
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN2924MUN2012 IN2012MN02924A (en) | 2010-07-30 | 2012-12-31 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US8268836B2 (en) |
| EP (1) | EP2598144B1 (en) |
| JP (1) | JP5738412B2 (en) |
| KR (1) | KR20130052740A (en) |
| CN (1) | CN103002898A (en) |
| AR (1) | AR085183A1 (en) |
| AU (1) | AU2011282973B2 (en) |
| BR (1) | BR112013002211A2 (en) |
| CA (1) | CA2805494A1 (en) |
| EA (1) | EA201270818A1 (en) |
| ES (1) | ES2516940T3 (en) |
| IN (1) | IN2012MN02924A (en) |
| MX (1) | MX2013001247A (en) |
| TW (1) | TWI431008B (en) |
| WO (1) | WO2012015677A1 (en) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6129956B2 (en) * | 2012-05-09 | 2017-05-17 | イーライ リリー アンド カンパニー | Anti-c-Met antibody |
| CN103122000B (en) | 2012-09-03 | 2013-12-25 | 中美冠科生物技术（太仓）有限公司 | High-selectivity c-Met kinase inhibitor used as antitumor drug |
| TWI667233B (en) | 2013-12-19 | 2019-08-01 | 德商拜耳製藥公司 | Novel indazolecarboxamides, processes for their preparation, pharmaceutical preparations comprising them and their use for producing medicaments |
| US10386376B2 (en) | 2015-11-09 | 2019-08-20 | Jeimei, Llc | Sample container with integrated test strip |
| CN106924260B (en) * | 2015-12-31 | 2018-05-25 | 北京浦润奥生物科技有限责任公司 | Application of compound in preparation of medicine for treating brain glioma |
| KR20210142154A (en) | 2019-03-21 | 2021-11-24 | 옹쎄오 | DBAIT molecules in combination with kinase inhibitors for the treatment of cancer |
| CN114761006A (en) | 2019-11-08 | 2022-07-15 | Inserm(法国国家健康医学研究院) | Methods of treating cancer resistant to kinase inhibitors |
| WO2021148581A1 (en) | 2020-01-22 | 2021-07-29 | Onxeo | Novel dbait molecule and its use |
| AU2024241633A1 (en) | 2023-03-30 | 2025-11-06 | Revolution Medicines, Inc. | Compositions for inducing ras gtp hydrolysis and uses thereof |
| WO2024229406A1 (en) | 2023-05-04 | 2024-11-07 | Revolution Medicines, Inc. | Combination therapy for a ras related disease or disorder |
| WO2025034702A1 (en) | 2023-08-07 | 2025-02-13 | Revolution Medicines, Inc. | Rmc-6291 for use in the treatment of ras protein-related disease or disorder |
| TW202530228A (en) | 2023-10-12 | 2025-08-01 | 美商銳新醫藥公司 | Ras inhibitors |
| WO2025171296A1 (en) | 2024-02-09 | 2025-08-14 | Revolution Medicines, Inc. | Ras inhibitors |
| WO2025240847A1 (en) | 2024-05-17 | 2025-11-20 | Revolution Medicines, Inc. | Ras inhibitors |
| WO2025255438A1 (en) | 2024-06-07 | 2025-12-11 | Revolution Medicines, Inc. | Methods of treating a ras protein-related disease or disorder |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2008007049A (en) * | 2005-11-30 | 2008-10-23 | Vertex Pharma | Inhibitors of c-met and uses thereof. |
| PE20121506A1 (en) * | 2006-07-14 | 2012-11-26 | Amgen Inc | TRIAZOLOPYRIDINE COMPOUNDS AS C-MET INHIBITORS |
| US8217177B2 (en) | 2006-07-14 | 2012-07-10 | Amgen Inc. | Fused heterocyclic derivatives and methods of use |
| PL2081937T3 (en) | 2006-10-23 | 2013-01-31 | Sgx Pharmaceuticals Inc | Triazolopyridazine protein kinase modulators |
| KR20090071612A (en) * | 2006-10-23 | 2009-07-01 | 에스지엑스 파마슈티컬스, 인코포레이티드 | Bicyclic Triazoles as Protein Kinase Modulators |
| SI2081937T1 (en) * | 2006-10-23 | 2012-11-30 | Sgx Pharmaceuticals Inc | Triazolopyridazine protein kinase modulators |
| PA8792501A1 (en) * | 2007-08-09 | 2009-04-23 | Sanofi Aventis | NEW DERIVATIVES OF 6-TRIAZOLOPIRIDACINA-SULFANIL BENZOTIAZOL AND BENCIMIDAZOL, ITS PREPARATION PROCEDURE, ITS APPLICATION AS MEDICATIONS, PHARMACEUTICAL COMPOSITIONS AND NEW MAIN USE AS MET INHIBITORS. |
| UY31676A1 (en) | 2008-02-28 | 2009-09-30 | "DERIVATIVES OF 3-METHYL-IMIDIAZO- [1,2-B] -PIRIDAZINA" |
-
2011
- 2011-07-20 AR ARP110102632A patent/AR085183A1/en unknown
- 2011-07-22 TW TW100126076A patent/TWI431008B/en not_active IP Right Cessation
- 2011-07-22 EP EP11741372.4A patent/EP2598144B1/en not_active Not-in-force
- 2011-07-22 AU AU2011282973A patent/AU2011282973B2/en not_active Expired - Fee Related
- 2011-07-22 JP JP2013521838A patent/JP5738412B2/en not_active Expired - Fee Related
- 2011-07-22 ES ES11741372.4T patent/ES2516940T3/en active Active
- 2011-07-22 BR BR112013002211A patent/BR112013002211A2/en not_active IP Right Cessation
- 2011-07-22 CN CN2011800371928A patent/CN103002898A/en active Pending
- 2011-07-22 US US13/188,496 patent/US8268836B2/en not_active Expired - Fee Related
- 2011-07-22 MX MX2013001247A patent/MX2013001247A/en not_active Application Discontinuation
- 2011-07-22 EA EA201270818A patent/EA201270818A1/en unknown
- 2011-07-22 CA CA2805494A patent/CA2805494A1/en not_active Abandoned
- 2011-07-22 WO PCT/US2011/044926 patent/WO2012015677A1/en not_active Ceased
- 2011-07-22 KR KR1020137002382A patent/KR20130052740A/en not_active Ceased
-
2012
- 2012-12-31 IN IN2924MUN2012 patent/IN2012MN02924A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR085183A1 (en) | 2013-09-18 |
| EP2598144A1 (en) | 2013-06-05 |
| US8268836B2 (en) | 2012-09-18 |
| WO2012015677A1 (en) | 2012-02-02 |
| KR20130052740A (en) | 2013-05-23 |
| EA201270818A1 (en) | 2013-05-30 |
| TWI431008B (en) | 2014-03-21 |
| ES2516940T3 (en) | 2014-10-31 |
| AU2011282973B2 (en) | 2014-03-20 |
| CA2805494A1 (en) | 2012-02-02 |
| US20120028984A1 (en) | 2012-02-02 |
| TW201219393A (en) | 2012-05-16 |
| AU2011282973A1 (en) | 2013-01-10 |
| JP2013532687A (en) | 2013-08-19 |
| MX2013001247A (en) | 2013-03-18 |
| EP2598144B1 (en) | 2014-08-13 |
| JP5738412B2 (en) | 2015-06-24 |
| WO2012015677A9 (en) | 2012-12-13 |
| BR112013002211A2 (en) | 2016-05-24 |
| CN103002898A (en) | 2013-03-27 |